Pilot Study of Percutaneous Correction of Hallux Valgus

Recruiting now · Not applicable

Conditions studied: Hallux Valgus

In brief

This is a pilot study with a randomized controlled design.

Key facts

Study ID

NCT05880407

Run by

Istituto Ortopedico Rizzoli

People needed

40

Starts

2022-02-22

Expected to finish

2026-12-31

Last updated by the study team

2026-05-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
• HVA (hallux valgus angle): 20°-40°
• IMA (intermetatarsal angle): 10°-20°

You may not qualify if…

• Patients with instability of the first metatarsophalangeal joint
• Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
• patients requiring additional surgical procedures
• patients with severe vascular and neurological systemic pathologies
• systemic pathologies that may impair bone consolidation

Where it is running

• Istituto Ortopedico Rizzoli — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.